Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
The International Journal of Cardiovascular Imaging
Metadata
Title
Editor’s note April, 2013
Author
Johan H. C. Reiber
Publication date
01-04-2013
Publisher
Springer Netherlands
Published in
The International Journal of Cardiovascular Imaging / Issue 4/2013
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-013-0211-0

Other articles of this Issue 4/2013

The International Journal of Cardiovascular Imaging 4/2013 Go to the issue

Original Paper

Ankle-brachial index (ABI), abdominal aortic calcification (AAC), and coronary artery calcification (CAC): the Jackson heart study

Original Paper

Beat to beat 3-dimensional intracardiac echocardiography: theoretical approach and practical experiences

Over View

Cardiovascular imaging 2012 in the International Journal of Cardiovascular Imaging

Original Paper

Application of a new three-dimensional method for the measurement of coronary stent angulation and comparison with conventional methods

Original Paper

Multimodality noninvasive cardiac imaging established the diagnosis of aneurysms of Vieussens’ arterial ring

COMMENTARY

Computed tomographic angiography prior to reoperative coronary artery bypass grafting: clinical benefit at the same cost

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits